Acropolis Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $215K | Buy |
482
+6
| +1% | +$2.67K | 0.01% | 232 |
|
|
2025
Q1 | $231K | Buy |
476
+3
| +0.6% | +$1.45K | 0.01% | 214 |
|
|
2024
Q4 | $190K | Buy |
473
+13
| +3% | +$5.24K | 0.01% | 237 |
|
|
2024
Q3 | $214K | Hold |
460
| – | – | 0.01% | 214 |
|
|
2024
Q2 | $216K | Sell |
460
-112
| -20% | -$52.5K | 0.01% | 213 |
|
|
2024
Q1 | $239K | Hold |
572
| – | – | 0.02% | 207 |
|
|
2023
Q4 | $233K | Hold |
572
| – | – | 0.02% | 204 |
|
|
2023
Q3 | $199K | Buy |
+572
| New | +$199K | 0.02% | 213 |
|